Pharmaceutical companies in France are warning about the consequences of possible gas cuts this winter and saying its 271 production sites must be prioritised for energy supply to ensure business continuity and treatments for patients.
Professional organisation Leem said the unprecedented energy crisis has a new impact on industrial production and requires “exceptional sobriety efforts” throughout France.
It said it was “very concerned” by the announcement of a rotating plan of energy shedding, which can be activated at the height of winter by the public authorities.
“Exemptions for certain establishments can be identified by prefectural decree. However, many pharmaceutical laboratories are currently being notified by the prefectures that they are not a priority, both for electricity and for gas,” it stated.
... to continue reading you must be subscribed
